Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Generalized Anxiety Disorder
NCT00475969Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Duloxetine with Placebo (2 arms). Primary endpoint: Hamilton Anxiety Rating Scale. Started Aug 2004; status: completed.
02
Drugs
duloxetine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00475969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475969.